PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 77 filers reported holding PREVAIL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,472,000 | -80.0% | 367,218 | -83.7% | 0.40% | -85.9% |
Q1 2020 | $27,407,000 | -23.0% | 2,248,306 | 0.0% | 2.86% | -10.8% |
Q4 2019 | $35,591,000 | +21.1% | 2,248,306 | -6.0% | 3.21% | -13.5% |
Q3 2019 | $29,381,000 | -7.0% | 2,392,556 | 0.0% | 3.71% | +16.3% |
Q2 2019 | $31,582,000 | – | 2,392,556 | – | 3.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 13,822,463 | $318,884,000 | 2.79% |
HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
EQUITEC PROPRIETARY MARKETS, LLC | 215,300 | $4,967,000 | 1.30% |
BARDIN HILL MANAGEMENT PARTNERS LP | 206,867 | $4,773,000 | 1.00% |
Boxer Capital, LLC | 1,123,105 | $25,910,000 | 0.83% |
TIG Advisors, LLC | 709,282 | $16,363,000 | 0.82% |
Newtyn Management, LLC | 153,617 | $3,544,000 | 0.82% |
ALPINE ASSOCIATES MANAGEMENT INC. | 857,705 | $19,787,000 | 0.81% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 205,800 | $4,748,000 | 0.74% |